Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101706293 | 10170629 | 3 | F | 20140620 | 20140514 | 20160815 | EXP | US-ROCHE-1398401 | ROCHE | 0.00 | F | Y | 82.17000 | KG | 20160815 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101706293 | 10170629 | 1 | PS | NUTROPIN AQ | SOMATROPIN | 1 | Subcutaneous | U | 20522 | .1 | MG | SOLUTION FOR INJECTION | QD | ||||||
| 101706293 | 10170629 | 2 | SS | NUTROPIN AQ | SOMATROPIN | 1 | Subcutaneous | U | 20522 | .2 | MG | SOLUTION FOR INJECTION | QD | ||||||
| 101706293 | 10170629 | 3 | SS | NUTROPIN AQ | SOMATROPIN | 1 | Subcutaneous | U | 20522 | .8 | MG | SOLUTION FOR INJECTION | QD | ||||||
| 101706293 | 10170629 | 4 | SS | CLONAZEPAM. | CLONAZEPAM | 1 | Oral | 17533 | 2 | MG | TABLET | ||||||||
| 101706293 | 10170629 | 5 | SS | ROCEPHIN | CEFTRIAXONE SODIUM | 1 | Unknown | U | 63239 | ||||||||||
| 101706293 | 10170629 | 6 | C | LEVOTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | EVERY MORNING EMPTY STOMACH | 0 | 100 | UG | QD | |||||||
| 101706293 | 10170629 | 7 | C | ROPINIROLE HYDROCHLORIDE. | ROPINIROLE HYDROCHLORIDE | 1 | Unknown | 0 | 5 | MG | BID | ||||||||
| 101706293 | 10170629 | 8 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | 10-12.5MG | 0 | TABLET | QD | ||||||||
| 101706293 | 10170629 | 9 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Unknown | 10-12.5MG | 0 | TABLET | QD | ||||||||
| 101706293 | 10170629 | 10 | C | PROMETHAZINE HCL | PROMETHAZINE HYDROCHLORIDE | 1 | Unknown | AT BEDTIME AS REQUIRED | 0 | 25 | MG | TABLET | QD | ||||||
| 101706293 | 10170629 | 11 | C | BACLOFEN. | BACLOFEN | 1 | Unknown | WITH FOOD OR MILK | 0 | 10 | MG | TABLET | BID | ||||||
| 101706293 | 10170629 | 12 | C | XOPENEX | LEVALBUTEROL HYDROCHLORIDE | 1 | Unknown | AS REQUIRED | 0 | ||||||||||
| 101706293 | 10170629 | 13 | C | ESTRADIOL. | ESTRADIOL | 1 | Unknown | 0 | 2 | MG | TABLET | QD | |||||||
| 101706293 | 10170629 | 14 | C | PYRIDIUM | PHENAZOPYRIDINE | 1 | Unknown | 0 | 100 | MG | TABLET | BID | |||||||
| 101706293 | 10170629 | 15 | C | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Unknown | 0 | 50 | MG | TABLET | QD | |||||||
| 101706293 | 10170629 | 16 | C | ALLEGRA | FEXOFENADINE HYDROCHLORIDE | 1 | Unknown | 0 | CAPSULE | ||||||||||
| 101706293 | 10170629 | 17 | C | BUTALBITAL WITH ACETAMINOPHEN | 2 | Unknown | AS REQUIRED | 0 | 4 | MG | CAPSULE | ||||||||
| 101706293 | 10170629 | 18 | C | PRAMIPEXOLE DIHYDROCHLORIDE. | PRAMIPEXOLE DIHYDROCHLORIDE | 1 | Unknown | 0 | 1 | MG | TABLET | BID | |||||||
| 101706293 | 10170629 | 19 | C | ESTRING | ESTRADIOL | 1 | Unknown | 1 RING EVERY 3 MONTHS | 0 | 2 | MG | ||||||||
| 101706293 | 10170629 | 20 | C | ESTRACE | ESTRADIOL | 1 | Unknown | 0.1MG/GM, AS DIRECTED ONCE A DAY | 0 | CREAM | QD | ||||||||
| 101706293 | 10170629 | 21 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Unknown | 0 | 40 | MG | CAPSULE | QD | |||||||
| 101706293 | 10170629 | 22 | C | AMITIZA | LUBIPROSTONE | 1 | Unknown | WITH FOOD OR MILK | 0 | 8 | UG | CAPSULE | BID | ||||||
| 101706293 | 10170629 | 23 | C | CREON | PANCRELIPASE AMYLASEPANCRELIPASE LIPASEPANCRELIPASE PROTEASE | 1 | Unknown | 24000 UNIT | 0 | CAPSULE | QD | ||||||||
| 101706293 | 10170629 | 24 | C | SUMATRIPTAN SUCCINATE. | SUMATRIPTAN SUCCINATE | 1 | Oral | 0 | 100 | MG | TABLET | ||||||||
| 101706293 | 10170629 | 25 | C | ZONISAMIDE. | ZONISAMIDE | 1 | Unknown | 0 | 100 | MG | CAPSULE | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 101706293 | 10170629 | 1 | Growth hormone deficiency |
| 101706293 | 10170629 | 4 | Product used for unknown indication |
| 101706293 | 10170629 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 101706293 | 10170629 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 101706293 | 10170629 | Anxiety | |
| 101706293 | 10170629 | Arthralgia | |
| 101706293 | 10170629 | Bone pain | |
| 101706293 | 10170629 | Chills | |
| 101706293 | 10170629 | Depression | |
| 101706293 | 10170629 | Drug hypersensitivity | |
| 101706293 | 10170629 | General physical health deterioration | |
| 101706293 | 10170629 | Glucose urine | |
| 101706293 | 10170629 | Headache | |
| 101706293 | 10170629 | Hepatic steatosis | |
| 101706293 | 10170629 | Hot flush | |
| 101706293 | 10170629 | Impaired gastric emptying | |
| 101706293 | 10170629 | Malaise | |
| 101706293 | 10170629 | Multiple organ dysfunction syndrome | |
| 101706293 | 10170629 | Myalgia | |
| 101706293 | 10170629 | Peripheral swelling | |
| 101706293 | 10170629 | Protein urine present | |
| 101706293 | 10170629 | Renal disorder | |
| 101706293 | 10170629 | Sleep disorder | |
| 101706293 | 10170629 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 101706293 | 10170629 | 2 | 20140312 | 0 | ||
| 101706293 | 10170629 | 3 | 201201 | 0 | ||
| 101706293 | 10170629 | 19 | 20140110 | 0 |